[Low molecular weight heparin in venous thromboembolism. Mechanism of action, therapy and prophylaxis].
Stammler
F
F
Abteilung Innere Medizin/Angiologie, Klinikum Karlsbad-Langensteinbach.
Diehm
C
C
D000208:Acute Disease; D000925:Anticoagulants / Q000009:adverse effects / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006701:Home Nursing; D006801:Humans; D008970:Molecular Weight; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000517:prevention & control; D012307:Risk Factors; D013924:Thrombophlebitis / Q000188:drug therapy* / Q000517:prevention & control
D000925:Anticoagulants; D006493:Heparin
Niedermolekulare Heparine bei venöser Thromboembolie. Wirkmechanismus, Therapie und Prophylaxe.